Aminder S. Mehdi

Aminder S. Mehdi

Hematology
2626 N California St
Ste B
Stockton, CA 95204

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study.

Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study.

Journal: The Lancet. Oncology
Published: October 08, 2013
Showing 1-1 of 1

Last Updated: 09/26/2026